Synairgen PLC (LSE:SNG) - Share price - Overview


Stock Report

Synairgen PLC SNG

Last Price
GBX13.25

Day Change
0.00|0.00%

As of 26/03/2019
10:51:29 GMT | GBX
Minimum 15 Minutes Delay.

Last Close13.25p
Day Range13.06 - 13.06
Mkt Cap14.48Mil
52-Wk Range10.00 - 27.00
Yield %-
ISINGB00B0381Z20
Volume644
P/E7.09
P/S0.02
P/CF0.06

Share Price

Total Returns 25/03/2019

 Chg (%)  
More ...
Synairgen PLC-17.19 
FTSE 100 TR GBP0.44
 
Financials
201520162017
More ...
Income Statement
Turnover0.030.005.03
Operating Profit-2.61-3.441.62
Net Profit-2.26-2.821.76
Reported EPS-2.47-3.081.87
Balance Sheet
Current Assets8.195.477.61
Non Current Assets0.100.080.06
Total Assets8.285.557.66
Current Liabilities0.940.861.10
Total Liabilities---
Total Equity7.354.696.56
Cash Flow
Operating Cash Flow-1.99-3.321.45
Net Change in Cash1.15-0.891.74
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
15/10/2018PurchaseMr Richard James Marsden16.00156,25025,000.00
15/10/2018PurchaseDr Phillip David Monk16.0046,8757,500.00
15/10/2018PurchaseJohn Christopher Ward16.0062,50010,000.00

Company Profile

Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 17/05/2019

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE24.62
Op Mrgn0.32
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr Richard James Marsden
Executive Director, Chief Scientific OfficerDr Phillip David Monk
Executive Director, Finance Director and Company SecretaryJohn Christopher Ward
Non-Executive DirectorMr. Paul Hugh Anthony Clegg
Non-Executive DirectorProf Stephen Townley Holgate CBE
Non-Executive DirectorMr. Iain Peter Murray Buchanan
Non-Executive Director, ChairmanMr. Simon James Blouet Shaw
Non-Executive DirectorDr David Bruce Campbell
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.